← Back to Search

Behavioral Intervention

Virtual facilitation (Stage 2) for Coronavirus

N/A
Waitlist Available
Led By Geoffrey Curran, PhD
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* The pharmacy must be a member of the Rural Research Alliance for Community Pharmacies (RURAL-CP).
* The pharmacy must be located in a county that has an African American population of at least 25% or had at least 51% of the population vote for a Republican president in 2020.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from baseline through the end of the virtual facilitation periods, up to 24 weeks maximum.
Awards & highlights

Summary

The goal of this clinical trial is to test if virtual facilitation (e.g., video coaching) increases rural pharmacists' ability to implement COVID-19 vaccine hesitancy counseling when compared to a "standard" implementation approach (e.g., training and dissemination of implementation support tools) in rural pharmacies. The main question it aims to answer is if virtual facilitation improves fidelity to a newly developed vaccine hesitancy counseling intervention when compared to standard implementation. All participants will begin in the standard implementation condition, where they will complete a webinar on COVID-19 vaccinations and a 30-minute online training on vaccine hesitancy communication. After standard implementation, they will switch to the virtual facilitation condition where they will be assigned a virtual coach to help them with implementing the intervention. There will be six fidelity observations per each 8-week intervention period to determine whether pharmacists are implementing the intervention as intended. Researchers will compare fidelity between the standard and virtual facilitation conditions.

Who is the study for?
This trial is for rural pharmacists who are looking to improve their ability to counsel patients with COVID-19 vaccine hesitancy. Participants should be currently practicing in a rural pharmacy and willing to undergo training and coaching sessions.
What is being tested?
The study tests if virtual coaching helps pharmacists better implement COVID-19 vaccine hesitancy counseling compared to just webinar training. Pharmacists start with standard online training, then move on to personalized video coaching, with their performance observed over time.
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, traditional physical side effects are not applicable. However, participants may experience increased workload or stress due to additional training and observation requirements.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline through the end of the virtual facilitation periods, up to 24 weeks maximum.
This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline through the end of the virtual facilitation periods, up to 24 weeks maximum. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Mean Fidelity Score
Secondary study objectives
Proportion of Individuals Receiving Vaccine Hesitancy Counseling Who Chose to Get the COVID-19 Vaccine

Trial Design

2Treatment groups
Experimental Treatment
Group I: Virtual facilitation (Stage 2)Experimental Treatment1 Intervention
After completing the standard implementation, participants then complete the virtual facilitation intervention for 8-16 weeks, depending on random block assignment.
Group II: Standard implementation (Stage 1)Experimental Treatment1 Intervention
Participants begin with the standard implementation interventions for 8-16 weeks, depending on random block assignment.

Find a Location

Who is running the clinical trial?

University of North Carolina, Chapel HillLead Sponsor
1,535 Previous Clinical Trials
4,198,255 Total Patients Enrolled
University of ArkansasOTHER
492 Previous Clinical Trials
150,960 Total Patients Enrolled
National Institute on Minority Health and Health Disparities (NIMHD)NIH
403 Previous Clinical Trials
1,346,129 Total Patients Enrolled
~20 spots leftby Mar 2026